# Wave 1 Data: Live-cell time-lapse microscopy of pyroptosis.

This dataset contains live-cell time-lapse microscopy of pyroptosis in SH-SY5Y cells.
The dataset was generated by Saguaro BioSciences and University of Montreal's imaging platform.

## Experimental Design
The dataset was generated by imaging SH-SY5Y cells that were treated with pyroptosis-inducing agents.
The cells were imaged every 3 hours for 48 hours using a 20x objective on a Yokogawa CQ1 cell voyager spinning disk confocal microscope.
The images were acquired with the following parameters:
* 20x objective - NA 0.80
* 96 wells on a 384-well plate
* 5 fields of view (FOV) per well
* 1 z-slice per FOV
* 4 channels

The images were acquired in 4 channels:
| Channel # | Channel Name | Excitation (nm) | Emission (nm) | Dye | Exposure (ms) |
|:---------:|:------------:|:----------:|:--------:|:------:|:---:|
| 1 | GSDMD | 488 | 525/50 | GFP | 50 |
| 2 | CL488 | 488 | 685/40 | Chromalive 488 | 400 |
| 3 | CL561 | 561 | 617/73 | Chromalive 561 | 700 |
| 4 | DNA | 405 | 447/60 | Hoechst 33342 | 600 |
| 5 | Brightfield | | | | 200 |

The following treatments were applied to the cells, a plate map is provided below:
| Well | Treatment | Treatment1 | Treatment2 | Treatment1 Dose | Treatment1 Unit | Treatment2 Dose | Treatment2 Unit | Serum |
|:----:|:---------:|:----------:|:----------:|:---------------:|:---------------:|:---------------:|:---------------:|:-----:|
| C04 | Media| Media |||||| FBS|
| C05 | DMSO CTL | DMSO|| CTL|||| FBS|
| C06 | Media| Media |||||| FBS|
| C07 | DMSO CTL | DMSO|| CTL|||| FBS|
| C08 | Media| Media |||||| FBS|
| C09 | DMSO CTL | DMSO|| CTL|||| FBS|
| C10 | Media| Media |||||| NuSerum|
| C11 | DMSO CTL | DMSO|| CTL|||| NuSerum|
| D04 | LPS 10 ug/ml| LPS|| 10| ug/ml ||| FBS|
| D05 | Thapsigargin 10 uM | Thapsigargin|| 10| uM||| FBS|
| D06 | LPS 10 ug/ml| LPS|| 10| ug/ml ||| FBS|
| D07 | Thapsigargin 10 uM | Thapsigargin|| 10| uM||| FBS|
| D08 | LPS 10 ug/ml| LPS|| 10| ug/ml ||| FBS|
| D09 | Thapsigargin 10 uM | Thapsigargin|| 10| uM||| FBS|
| D10 | LPS 10 ug/ml| LPS|| 10| ug/ml ||| NuSerum|
| D11 | Thapsigargin 10 uM | Thapsigargin|| 10| uM||| NuSerum|
| E04 | LPS 1 ug/ml| LPS|| 1 | ug/ml ||| FBS|
| E05 | Thapsigargin 1 uM| Thapsigargin|| 1 | uM||| FBS|
| E06 | LPS 1 ug/ml| LPS|| 1 | ug/ml ||| FBS|
| E07 | Thapsigargin 1 uM| Thapsigargin|| 1 | uM||| FBS|
| E08 | LPS 1 ug/ml| LPS|| 1 | ug/ml ||| FBS|
| E09 | Thapsigargin 1 uM| Thapsigargin|| 1 | uM||| FBS|
| E10 | LPS 1 ug/ml| LPS|| 1 | ug/ml ||| NuSerum|
| E11 | Thapsigargin 1 uM| Thapsigargin|| 1 | uM||| NuSerum|
| F04 | LPS 0.1 ug/ml| LPS|| 0.1| ug/ml ||| FBS|
| F05 | Thapsigargin 0.5uM | Thapsigargin|| 0.5| uM||| FBS|
| F06 | LPS 0.1 ug/ml| LPS|| 0.1| ug/ml ||| FBS|
| F07 | Thapsigargin 0.5uM | Thapsigargin|| 0.5| uM||| FBS|
| F08 | LPS 0.1 ug/ml| LPS|| 0.1| ug/ml ||| FBS|
| F09 | Thapsigargin 0.5uM | Thapsigargin|| 0.5| uM||| FBS|
| F10 | LPS 0.1 ug/ml| LPS|| 0.1| ug/ml ||| NuSerum|
| F11 | Thapsigargin 0.5uM | Thapsigargin|| 0.5| uM||| NuSerum|
| G04 | LPS 1 ug/ml + ATP 2.5 mM | LPS| ATP| 1 | ug/ml | 2.5| mM| FBS|
| G05 | LPS 1 ug/ml + Nigericin 5uM| LPS| Nigericin| 1 | ug/ml | 5 | uM| FBS|
| G06 | LPS 1 ug/ml + ATP 2.5 mM | LPS| ATP| 1 | ug/ml | 2.5| mM| FBS|
| G07 | LPS 1 ug/ml + Nigericin 5uM| LPS| Nigericin| 1 | ug/ml | 5 | uM| FBS|
| G08 | LPS 1 ug/ml + ATP 2.5 mM | LPS| ATP| 1 | ug/ml | 2.5| mM| FBS|
| G09 | LPS 1 ug/ml + Nigericin 5uM| LPS| Nigericin| 1 | ug/ml | 5 | uM| FBS|
| G10 | LPS 1 ug/ml + ATP 2.5 mM | LPS| ATP| 1 | ug/ml | 2.5| mM| NuSerum|
| G11 | LPS 1 ug/ml + Nigericin 5uM| LPS| Nigericin| 1 | ug/ml | 5 | uM| NuSerum|
| H04 | Flagellin 10 ug/ml | Flagellin || 10| ug/ml ||| FBS|
| H05 | LPS 1 ug/ml + Nigericin 3uM| LPS| Nigericin| 1 | ug/ml | 3 | uM| FBS|
| H06 | Flagellin 10 ug/ml | Flagellin || 10| ug/ml ||| FBS|
| H07 | LPS 1 ug/ml + Nigericin 3uM| LPS| Nigericin| 1 | ug/ml | 3 | uM| FBS|
| H08 | Flagellin 10 ug/ml | Flagellin || 10| ug/ml ||| FBS|
| H09 | LPS 1 ug/ml + Nigericin 3uM| LPS| Nigericin| 1 | ug/ml | 3 | uM| FBS|
| H10 | Flagellin 10 ug/ml | Flagellin || 10| ug/ml ||| NuSerum|
| H11 | LPS 1 ug/ml + Nigericin 3uM| LPS| Nigericin| 1 | ug/ml | 3 | uM| NuSerum|
| I04 | Flagellin 1 ug/ml | Flagellin || 1| ug/ml ||| FBS|
| I05 | LPS 1 ug/ml + Nigericin 1uM| LPS| Nigericin| 1 | ug/ml | 1 | uM| FBS|
| I06 | Flagellin 1 ug/ml | Flagellin || 1| ug/ml ||| FBS|
| I07 | LPS 1 ug/ml + Nigericin 1uM| LPS| Nigericin| 1 | ug/ml | 1 | uM| FBS|
| I08 | Flagellin 1 ug/ml | Flagellin || 1| ug/ml ||| FBS|
| I09 | LPS 1 ug/ml + Nigericin 1uM| LPS| Nigericin| 1 | ug/ml | 1 | uM| FBS|
| I10 | Flagellin 1 ug/ml | Flagellin || 1| ug/ml ||| NuSerum|
| I11 | LPS 1 ug/ml + Nigericin 1uM| LPS| Nigericin| 1 | ug/ml | 1 | uM| NuSerum|
| J04 | Flagellin 0.1 ug/ml | Flagellin || 0.1| ug/ml ||| FBS|
| J05 | LPS 1 ug/ml + Nigericin 0.5uM| LPS| Nigericin| 1 | ug/ml | 0.5 | uM| FBS|
| J06 | Flagellin 0.1 ug/ml | Flagellin || 0.1| ug/ml ||| FBS|
| J07 | LPS 1 ug/ml + Nigericin 0.5uM| LPS| Nigericin| 1 | ug/ml | 0.5 | uM| FBS|
| J08 | Flagellin 0.1 ug/ml | Flagellin || 0.1| ug/ml ||| FBS|
| J09 | LPS 1 ug/ml + Nigericin 0.5uM| LPS| Nigericin| 1 | ug/ml | 0.5 | uM| FBS|
| J10 | Flagellin 0.1 ug/ml | Flagellin || 0.1| ug/ml ||| NuSerum|
| J11 | LPS 1 ug/ml + Nigericin 0.5uM| LPS| Nigericin| 1 | ug/ml | 0.5 | uM| NuSerum|
| K04 | H202 500 uM | H202 || 500| uM ||| FBS|
| K05 | LPS 1 ug/ml + Nigericin 0.1uM| LPS| Nigericin| 1 | ug/ml | 0.1 | uM| FBS|
| K06 | H202 500 uM | H202 || 500| uM ||| FBS|
| K07 | LPS 1 ug/ml + Nigericin 0.1uM| LPS| Nigericin| 1 | ug/ml | 0.1 | uM| FBS|
| K08 | H202 500 uM | H202 || 500| uM ||| FBS|
| K09 | LPS 1 ug/ml + Nigericin 0.1uM| LPS| Nigericin| 1 | ug/ml | 0.1 | uM| FBS|
| K10 | H202 500 uM | H202 || 500| uM ||| NuSerum|
| K11 | LPS 1 ug/ml + Nigericin 0.1uM| LPS| Nigericin| 1 | ug/ml | 0.1 | uM| NuSerum|
| L04 | H202 100 uM | H202 || 100| uM ||| FBS|
| L05 | Ab1-42 10 uM | Ab1-42 || 10| uM ||| FBS|
| L06 | H202 100 uM | H202 || 100| uM ||| FBS|
| L07 | Ab1-42 10 uM | Ab1-42 || 10| uM ||| FBS|
| L08 | H202 100 uM | H202 || 100| uM ||| FBS|
| L09 | Ab1-42 10 uM | Ab1-42 || 10| uM ||| FBS|
| L10 | H202 100 uM | H202 || 100| uM ||| NuSerum|
| L11 | Ab1-42 10 uM | Ab1-42 || 10| uM ||| NuSerum|
| M04 | H202 100 nm | H202 || 100| nM ||| FBS|
| M05 | Ab1-42 2 uM | Ab1-42 || 2| uM ||| FBS|
| M06 | H202 100 nm | H202 || 100| nM ||| FBS|
| M07 | Ab1-42 2 uM | Ab1-42 || 2| uM ||| FBS|
| M08 | H202 100 nm | H202 || 100| nM ||| FBS|
| M09 | Ab1-42 2 uM | Ab1-42 || 2| uM ||| FBS|
| M10 | H202 100 nm | H202 || 100| nM ||| NuSerum|
| M11 | Ab1-42 2 uM | Ab1-42 || 2| uM ||| NuSerum|
| N04 | No Hoechst | No Hoechst |||||| FBS|
| N05 | Ab1-42 0.4 uM | Ab1-42 || 0.4| uM ||| FBS|
| N06 | No Hoechst | No Hoechst |||||| FBS|
| N07 | Ab1-42 0.4 uM | Ab1-42 || 0.4| uM ||| FBS|
| N08 | No Hoechst | No Hoechst |||||| FBS|
| N09 | Ab1-42 0.4 uM | Ab1-42 || 0.4| uM ||| FBS|
| N10 | No Hoechst | No Hoechst |||||| NuSerum|
| N11 | Ab1-42 0.4 uM | Ab1-42 || 0.4| uM ||| NuSerum|

## Data
This wave 1 data is preliminary and generated to identify the best conditions for imaging pyroptosis in SH-SY5Y cells.
The data has the following naming convention:
* `YYYYMMDDTHHMMSS_`
* `W####F####T####Z###C#.tif`
* `YYYYMMDDTHHMMSS`: Date and time of image acquisition
* `W####`: Well number
* `F####`: Field of view number
* `T####`: Timepoint number
* `Z###`: Z-slice number
* `C#`: Channel number

## Processing
### Preprocessing
These raw data are preprocessed into single well, single field of view, single timepoint, single z-slice images directories with all channels.
This allows for each FOV to be processed independently.

### Illumination Correction

### Image-based profiling

### Image-based profile processing
